None
Quote | Eton Pharmaceutcials Inc. (NASDAQ:ETON)
Last: | $3.51 |
---|---|
Change Percent: | -1.43% |
Open: | $3.55 |
Close: | $3.51 |
High: | $3.56 |
Low: | $3.46 |
Volume: | 57,334 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Eton Pharmaceutcials Inc. (NASDAQ:ETON)
2024-07-16 07:26:43 ET More on Eton Pharmaceuticals Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Eton Pharmaceuticals Historical earnings data for Eton Pharmaceuticals Financial information for Eton Pharma...
- Prescription Drug User Fee Act (PDUFA) target action date is February 28, 2025 - - Product has patent protection through 2043 - DEER PARK, Ill., July 15, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innov...
Message Board Posts | Eton Pharmaceutcials Inc. (NASDAQ:ETON)
Subject | By | Source | When |
---|---|---|---|
$ETON Price now | BioSpecialist | investorshub | 06/22/2023 9:27:54 AM |
The now | BioSpecialist | investorshub | 06/21/2023 4:39:49 PM |
$ETON MomentumIts gaining | BioSpecialist | investorshub | 06/20/2023 5:54:05 PM |
$ETON The gaining up | BioSpecialist | investorshub | 06/20/2023 10:51:26 AM |
Price trading last up | Toddrobertking | investorshub | 06/18/2023 3:15:56 AM |
News, Short Squeeze, Breakout and More Instantly...
Eton Pharmaceutcials Inc. Company Name:
ETON Stock Symbol:
NASDAQ Market:
Eton Pharmaceutcials Inc. Website:
- Prescription Drug User Fee Act (PDUFA) target action date is February 28, 2025 - - Product has patent protection through 2043 - DEER PARK, Ill., July 15, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innov...
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13 th straight quarter of sequential product sales growth • Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...